Botox Gone Wrong: UK Patient Guide 2026

Published 2026-05-11 · By the ClinicSpark Editorial Team

Fact-checked against UK regulatory sources (GDC, CQC, ASA/CAP, MHRA). Last reviewed: April 2026.

What can go wrong with Botox

"Botox" in popular usage covers all botulinum toxin treatments (Botox, Azzalure, Bocouture, Alluzience and similar brands). It is a Prescription-Only Medicine (POM) in the UK and can only lawfully be prescribed by a registered prescriber after a face-to-face assessment. When used at the small doses given for cosmetic facial treatment, the risk of a serious adverse event is low. Most patients have either no side effects or short-lived minor ones. A smaller number experience complications that need clinical management. The combination of practitioner training, premises, prescribing pathway and product authenticity drives outcome more than the medicine itself.

For an independent overview of botulinum toxin safety see the peer-reviewed safety review on PubMed Central and the US CDC monitoring of botulism-like reactions linked to mishandled or counterfeit product.

Common short-term effects (usually self-limiting)

• Mild bruising or redness at injection sites for 1–3 days;
• Mild headache for 24–48 hours;
• A short period of muscle tightness or heaviness as the product takes effect (3–14 days);
• Transient flu-like symptoms;
• Asymmetry as the treatment evolves over the first 1–2 weeks.

These usually resolve without intervention. If they persist beyond 2 weeks or worsen, contact your practitioner.

Complications that need clinical attention

1. Ptosis (drooping eyelid)

The most-discussed Botox complication. Drooping of the upper eyelid happens when toxin diffuses to the levator muscle, usually because of incorrect injection location, dose or post-procedure behaviour (rubbing the area, lying down too soon). Visible droop typically appears within 1–2 weeks and resolves as toxin effect wears off over 4–12 weeks. Significant droop that affects vision should be reviewed by a practitioner or an ophthalmologist. Apraclonidine eye drops can sometimes mitigate visible droop in the interim.

2. Brow asymmetry or "Spock brow"

Uneven brow position after frown-line treatment. Usually caused by under-treating one side or differential muscle response. Easily corrected with a small top-up by an experienced injector at the 2-week review. Reputable clinics include a complimentary 2-week review specifically to address this.

3. Inability to fully close the eye or smile

If toxin diffuses to nearby muscles it can transiently weaken normal facial expression. Effects resolve as the toxin wears off but the patient often finds the period unsettling. Photograph progression and review with the practitioner.

4. Headache — persistent or severe

A short headache for 1–2 days is common. A severe persistent headache lasting beyond 72 hours, particularly if associated with other neurological symptoms (vision change, neck stiffness, confusion), needs urgent medical review and is a 999 call if accompanied by stroke-like symptoms.

5. Infection at the injection site

Any injection through skin carries a small risk of bacterial infection. Signs include spreading redness, warmth, pus discharge or fever. Untreated infection can require oral or intravenous antibiotics. Sterile technique and a properly cleaned clinical environment reduce risk.

6. Allergic reaction or hypersensitivity

Allergic reactions to botulinum toxin are rare. Mild local hypersensitivity (red, itchy site) usually settles. Severe systemic reactions (widespread rash, facial swelling beyond treatment site, throat tightness, breathing difficulty) are a 999 emergency.

7. Distant or systemic spread (very rare)

At cosmetic doses, clinically significant systemic effect is very rare. The MHRA and FDA have issued safety communications about the theoretical risk of distant spread (weakness, swallowing difficulty, breathing difficulty), particularly with higher therapeutic doses or with counterfeit product. Difficulty swallowing or breathing after treatment is always a 999 emergency.

8. Counterfeit or improperly stored product

Counterfeit botulinum toxin reaches the UK market through unregulated channels. The CDC has documented clusters of botulism-like reactions linked to counterfeit or mishandled product. Symptoms can include severe muscle weakness extending beyond the injection site, vision changes, swallowing difficulty and respiratory weakness — all 999 emergencies. See our counterfeit anti-wrinkle product guide.

Why complications happen — the UK context

The UK has a strange regulatory pattern: the medicine itself is tightly controlled (POM, requires face-to-face prescriber assessment), but the actual injection has not been a regulated activity in itself in 2026. This creates three structural risk drivers:

1. Prescriber-injector mismatch. Some clinics use remote prescribers who never assess the patient face-to-face. This is unlawful in UK practice and means the prescribing safety net is absent.
2. Premises are inconsistently regulated. Beauty salons, hotel rooms and private homes are reported in patient-harm cases. Dental practices, doctor-led clinics and PSA-recognised aesthetic providers operate under different standards.
3. Product provenance varies. Genuine UK botulinum toxin enters the country through licensed wholesalers with traceable batch and cold-chain records. Counterfeit product reaches the market through unregulated channels — cheaper, but with no guarantee of authenticity or storage.

The proposed UK aesthetics licensing scheme (consultation response August 2025; not yet in force) will introduce a local-authority licence for amber-category procedures including botulinum toxin once enacted. Until then, patient vigilance and provider selection are the most reliable safeguards. See our 2025-2026 regulatory update.

Reducing your risk before booking

1. Verify the practitioner on a statutory register. GDC for dentists, GMC for doctors, NMC for nurses, GPhC for pharmacists. Get the registration number and check the public register directly.
2. Confirm the prescribing pathway. Is the person performing the consultation also the prescriber? If not, who is, and has that prescriber assessed you face-to-face? Remote prescribing for botulinum toxin is unlawful in UK practice.
3. Check voluntary accreditation. Save Face is PSA-recognised. JCCP is another credible signal.
4. Ask about product source and batch. "What brand do you use and where do you buy it from?" Reputable practitioners answer without hesitation. Botulinum toxin requires cold-chain storage; ask where it is kept.
5. Confirm the premises type. Dental practices in England are CQC-registered for dentistry, with documented infection-control and controlled-drug-storage protocols. Beauty salons and home settings are not.
6. Be cautious of unusually cheap pricing. A treatment offered well below typical UK market range often signals counterfeit product or absent prescribing pathway. See our anti-wrinkle treatment cost guide.
7. Avoid social-media-style mass events. "Botox parties" in salons, hotels or homes are the highest-risk version of the market.

What to do if you suspect a Botox complication

1. Contact the practitioner immediately for non-emergency concerns.
2. Call NHS 111 if the practitioner is unreachable or dismissive.
3. Call 999 for: difficulty swallowing or breathing, severe spreading muscle weakness, sudden vision loss, severe drooping eyelid affecting sight, anaphylaxis-style symptoms (facial swelling, widespread rash, breathing difficulty).
4. Document everything. Photographs at intervals, consent paperwork, receipts, all correspondence.
5. Report counterfeit or sub-standard product to the MHRA Yellow Card scheme.
6. Report the practitioner to the relevant professional regulator (GDC, GMC, NMC, GPhC). Save Face and JCCP investigate complaints against their registered practitioners. The CQC investigates premises concerns in England.
7. Consider clinical-negligence advice if the case warrants it.

Dentist-led Botox: the structural argument

Dentist-led aesthetics clinics in the UK have several features relevant to anti-wrinkle treatment safety:

• GDC-registered prescriber on-site: the dentist can lawfully prescribe botulinum toxin (where they have completed the relevant training) and assess the patient face-to-face. The prescribing pathway is the same person performing the procedure;
• CQC-registered premises (England) with established infection-control, controlled-drug-storage and clinical-governance frameworks;
• Detailed facial anatomy training as part of undergraduate dental study;
• Cold-chain medicine handling and sharps disposal are part of routine dental practice.

None of this guarantees a specific outcome. Patients should still verify GDC registration, ask about injector training and check accreditation. ClinicSpark lists UK dentist-led aesthetics clinics with regulator and accreditation status displayed where independently confirmed.

Bottom line

Botulinum toxin is, on balance, a well-tolerated medicine at cosmetic facial doses when prescribed and administered by a properly qualified UK practitioner in a regulated setting. Serious complications are uncommon but real, and their severity depends heavily on practitioner training, premises and product authenticity. Use the questions above before booking and act fast on warning signs after.